Northwest Biotherapeutics | NWBO - Capital Ordinaire





Capital Ordinaire Changement Date
Agenus USD 35.32M 2.51M 2025-12
AstraZeneca USD 1.55B 206K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Celldex Therapeutics USD 66.55M 102K 2025-12
Eisai JPY 282.11M 1000 2025-12
Infinity Pharmaceuticals USD 90K 1000 2023-06
Merck USD 2.49B 15.79M 2025-09
Northwest Biotherapeutics USD 1.52B 1.52B 2025-09
Pfizer USD 5.69B 1000K 2025-09
Plus Therapeutics USD 138.68M 7.07M 2025-12
Roche Holding CHF 795.62M 699.54K 2025-12